Erdafitinib 4 Mg Tablet

Erdafixen (Erdafitinib), generic Balversa is a prescription medicine used to treat adult patients with locally advanced or metastatic Urothelial Carcinoma (bladder cancer) that has susceptible FGFR3 or FGFR2 genetic alterations and progressed during or following at least one line of prior platinum-containing chemotherapy, including within 12 months of neoadjuvant or adjuvant platinum-containing chemotherapy. Erdafixen manufactured by Everest Pharma in Bangladesh.

Erdafitinib is used to treat certain types of urothelial cancer (cancer of the lining of the bladder and other parts of the urinary tract) that spread to nearby tissues or other parts of the body that cannot be removed by surgery and has worsened during or after being treated with other chemotherapy medications.